E
Ezisurg Medical
Produces medical instruments for minimally invasive surgery
About Ezisurg Medical
Ezisurg Medical, established in November 2011 by founder Henry Nie, is a Shanghai-based company operating in the surgical devices market. The firm is focused on the research, development, and commercialization of devices for minimally invasive surgery (MIS). Ezisurg serves hospitals, surgeons, and their patients by providing a portfolio of surgical stapling products, energy devices, and endoscopy platforms. These tools are utilized in a variety of procedures, including general, bariatric, thoracic, colorectal, and urologic surgeries.
The company's business model centers on manufacturing and selling these high-end MIS products globally. A significant milestone was achieved in March 2025 when Ezisurg's U.S. subsidiary secured a supplier agreement with Vizient, Inc., one of the largest group purchasing organizations (GPOs) in the United States, granting it access to a vast network of healthcare providers. This positions the company within the U.S. surgical staplers market, which was valued at $2.1 billion in 2023. Ezisurg's products are used in over 1,400 hospitals in China and have received entry approvals in more than 80 countries, holding numerous global certifications, including FDA approvals and CE marks.
Ezisurg's product lineup includes the easyEndo™ series of linear cutting staplers, which are notable for features such as a 60-degree articulation angle, exceeding that of some established brands, and a design enabling one-handed operation. Another key product is the easyUS™ Ultrasonic Surgical System, an advanced ultrasonic scalpel designed to simultaneously cut tissue and provide hemostasis with minimal lateral thermal damage and less smoke compared to traditional electrocautery. The company has received multiple rounds of venture capital funding from investors including Hillhouse Investment Group, BioTrack Capital, and IDG Capital to support its growth and product development.
Source: Dealroom company dataNews
Open roles
Ezisurg Medical in the Huangpu ecosystem
The Ezisurg Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Shanghai Pudong Science and Technology Investment
Xiamen C&D
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ezisurg Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ezisurg Medical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.